Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms

BACKGROUND: Fluoropyrimidines and platinum are still widely used for colorectal cancer (CRC) management. Several studies have reported that mutations of dihydropyrimidine dehydrogenase (DPYD) and glutathione S-transferase pi-1 (GSTP1) polymorphisms are related to chemotherapy-related adverse events....

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xunwei, Hou, Jingyuan, Deng, Qiaoting, Zhong, Zhixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720377/
https://www.ncbi.nlm.nih.gov/pubmed/33280607
http://dx.doi.org/10.1186/s12957-020-02103-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720377/
https://www.ncbi.nlm.nih.gov/pubmed/33280607
http://dx.doi.org/10.1186/s12957-020-02103-3

Ejemplares similares